Description
FibroScan: The Gold Standard for Non-Invasive Liver Assessment
FibroScan (Transient Elastography) is an advanced, non-invasive diagnostic tool used to assess liver stiffness and fat content, playing a crucial role in evaluating chronic liver diseases such as MAFLD, viral hepatitis, alcohol-related liver disease, and cirrhosis. By measuring Liver Stiffness Measurement (LSM) in kilopascals (kPa) and Controlled Attenuation Parameter (CAP) in dB/m, FibroScan helps quantify fibrosis (scarring) and steatosis (fat accumulation) with high accuracy, reducing the need for liver biopsies.
Key Features & Clinical Utility:
🔹 Quick & Painless: Takes 5-10 minutes, performed at the bedside, and requires no sedation.
🔹 Early Detection: Identifies fibrosis progression in at-risk populations before symptoms appear.
🔹 Risk Stratification: Differentiates between simple fatty liver and advanced fibrosis/cirrhosis, guiding treatment decisions.
🔹 Monitoring Tool: Tracks liver disease progression or regression post-intervention (weight loss, antiviral therapy, or metabolic control).
Interpreting Results:
✔️ CAP Score (dB/m):
<248 dB/m: Minimal or no fat
248–280 dB/m: Mild steatosis
>280 dB/m: Significant fat accumulation (severe steatosis)
✔️ LSM (kPa):
<7 kPa: No/mild fibrosis
7-12 kPa: Moderate fibrosis (F2-F3)
>12 kPa: Advanced fibrosis/cirrhosis (F4)
Why It Matters?
With the rising burden of MAFLD & liver-related complications, FibroScan is transforming hepatology practice—allowing early diagnosis, risk prediction, and personalized liver care without invasive procedures.
#FibroScan #LiverHealth #FattyLiver #Cirrhosis #Hepatology #NonInvasiveTesting #PrecisionMedicine
#drchetankalal #besthepatologistmumbai # besthepatologistindia
